Published in Infect Immun on July 01, 2000
Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum. Clin Microbiol Rev (2011) 1.44
Persistent Ehrlichia chaffeensis infection occurs in the absence of functional major histocompatibility complex class II genes. Infect Immun (2002) 1.27
The biological basis of severe outcomes in Anaplasma phagocytophilum infection. FEMS Immunol Med Microbiol (2011) 1.09
Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a. Infect Immun (2002) 0.94
Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury. Clin Vaccine Immunol (2006) 0.92
Receptor interacting protein-2 contributes to host defense against Anaplasma phagocytophilum infection. FEMS Immunol Med Microbiol (2012) 0.83
Adaptive immunity to Anaplasma pathogens and immune dysregulation: implications for bacterial persistence. Comp Immunol Microbiol Infect Dis (2012) 0.81
Immune response in mice that lack the interferon-gamma receptor. Science (1993) 12.15
Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell (1995) 7.13
Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med (1996) 5.35
Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci U S A (1996) 5.34
Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest (1997) 4.62
Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity (1999) 4.47
Inducible nitric oxide synthase: what difference does it make? J Clin Invest (1997) 3.72
Two cytosolic components of the human neutrophil respiratory burst oxidase translocate to the plasma membrane during cell activation. J Clin Invest (1990) 2.56
Human ehrlichioses: newly recognized infections transmitted by ticks. Annu Rev Med (1998) 2.25
The human ehrlichioses in the United States. Emerg Infect Dis (1999) 2.22
Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun (1998) 1.89
Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis. J Exp Med (1997) 1.77
Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect Immun (1999) 1.59
Human monocytic and granulocytic ehrlichioses. Discovery and diagnosis of emerging tick-borne infections and the critical role of the pathologist. Arch Pathol Lab Med (1997) 1.58
Cutting edge: infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox. J Immunol (2000) 1.57
Mice lacking reduced nicotinamide adenine dinucleotide phosphate oxidase activity show increased susceptibility to early infection with Listeria monocytogenes. J Immunol (1997) 1.56
Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J Clin Invest (1997) 1.56
Human granulocytic ehrlichiosis in western Europe. N Engl J Med (1999) 1.55
Granulocytic ehrlichiosis in the laboratory mouse. J Infect Dis (1998) 1.37
The agent of Human Granulocytic Ehrlichiosis resides in an endosomal compartment. J Clin Invest (1998) 1.31
Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis. J Infect Dis (1997) 1.20
Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system. J Infect Dis (1999) 1.18
Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes. J Clin Microbiol (1997) 1.12
Human granulocytic ehrlichiosis in Bulgaria. Am J Trop Med Hyg (1999) 0.95
Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med (1998) 6.18
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med (1996) 5.46
Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med (1997) 4.06
Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease. Infect Immun (1994) 3.59
Borrelia burgdorferi genes selectively expressed in the infected host. Proc Natl Acad Sci U S A (1995) 3.42
Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding. Am J Trop Med Hyg (1995) 3.04
Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect Immun (1995) 2.86
Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease. J Immunol (1991) 2.61
Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J Clin Invest (2000) 2.56
Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity (2000) 2.54
Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice. Infect Immun (1994) 2.42
Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol (1995) 2.32
Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host. J Clin Invest (1997) 2.13
Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J Infect Dis (1992) 2.11
Arthropod- and host-specific gene expression by Borrelia burgdorferi. J Clin Invest (1997) 2.05
Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks. Infect Immun (1999) 1.96
Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect Immun (1997) 1.93
Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infect Immun (1998) 1.92
The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun (1999) 1.79
Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin Infect Dis (1997) 1.74
The early humoral response in human granulocytic ehrlichiosis. J Infect Dis (1997) 1.67
Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis. J Clin Microbiol (1996) 1.62
Immunization of mice against West Nile virus with recombinant envelope protein. J Immunol (2001) 1.60
Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody. J Immunol (2001) 1.58
Cutting edge: infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox. J Immunol (2000) 1.57
Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J Clin Invest (1997) 1.56
Human granulocytic ehrlichiosis in western Europe. N Engl J Med (1999) 1.55
Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens. J Clin Microbiol (2000) 1.53
Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity. Infect Immun (2000) 1.53
Immune evasion by tickborne and host-adapted Borrelia burgdorferi. J Infect Dis (1998) 1.52
Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients. J Infect Dis (1994) 1.50
Borrelia burgdorferi erpT expression in the arthropod vector and murine host. Mol Microbiol (1999) 1.50
Salp25D, an Ixodes scapularis antioxidant, is 1 of 14 immunodominant antigens in engorged tick salivary glands. J Infect Dis (2001) 1.45
A monoclonal antibody to OspA inhibits association of Borrelia burgdorferi with human endothelial cells. Infect Immun (1993) 1.43
Effect of anti-interleukin 12 treatment on murine lyme borreliosis. J Clin Invest (1996) 1.42
Prevention of Borrelia burgdorferi transmission in guinea pigs by tick immunity. Am J Trop Med Hyg (1998) 1.40
The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis. J Infect Dis (2000) 1.39
OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks. Infect Immun (1997) 1.38
Granulocytic ehrlichiosis in the laboratory mouse. J Infect Dis (1998) 1.37
Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis. Infect Immun (2001) 1.36
Infections of granulocytic ehrlichiae and Borrelia burgdorferi in white-tailed deer in Connecticut. J Wildl Dis (1999) 1.32
The agent of Human Granulocytic Ehrlichiosis resides in an endosomal compartment. J Clin Invest (1998) 1.31
Novel Borrelia burgdorferi isolates from Ixodes scapularis and Ixodes dentatus ticks feeding on humans. J Clin Microbiol (1996) 1.31
Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut. J Clin Microbiol (1998) 1.30
Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect Immun (2000) 1.29
Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect Immun (2001) 1.26
Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines. J Exp Med (1993) 1.23
A novel family of anticoagulants from the saliva of Ixodes scapularis. Insect Mol Biol (2002) 1.21
Molecular characterization of the humoral response to the 41-kilodalton flagellar antigen of Borrelia burgdorferi, the Lyme disease agent. Infect Immun (1991) 1.19
A chromosomal Borrelia burgdorferi gene encodes a 22-kilodalton lipoprotein, P22, that is serologically recognized in Lyme disease. J Clin Microbiol (1994) 1.18
Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis. J Infect Dis (1998) 1.17
Long-term study of cell-mediated responses to Borrelia burgdorferi in the laboratory mouse. Infect Immun (1993) 1.17
A 55-kilodalton antigen encoded by a gene on a Borrelia burgdorferi 49-kilobase plasmid is recognized by antibodies in sera from patients with Lyme disease. Infect Immun (1995) 1.14
Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin. Clin Infect Dis (1998) 1.14
Biochemical and functional characterization of Salp20, an Ixodes scapularis tick salivary protein that inhibits the complement pathway. Insect Mol Biol (2007) 1.14
Borrelia burgdorferi genes selectively expressed in ticks and mammals. Parasitol Today (1997) 1.12
Lyme borreliosis vaccination: the facts, the challenge, the future. Trends Parasitol (2010) 1.12
Identification of Aeromonas hydrophila hybridization group 1 by PCR assays. Appl Environ Microbiol (1996) 1.11
Comparison of whole-cell antibodies and an antigenic flagellar epitope of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis. J Clin Microbiol (1992) 1.11
OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks. Vector Borne Zoonotic Dis (2001) 1.09
Influence of growth temperature on the production of extracellular virulence factors and pathogenicity of environmental and human strains of Aeromonas hydrophila. J Appl Bacteriol (1993) 1.09
Molecular cloning and characterization of an extracellular protease gene from Aeromonas hydrophila. J Bacteriol (1990) 1.08
Safety and immunogenicity of an outer surface protein A vaccine in subjects with previous Lyme disease. J Infect Dis (1995) 1.07
Reactivity of human sera to different strains of granulocytic ehrlichiae in immunodiagnostic assays. J Infect Dis (1998) 1.06
Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection. J Clin Microbiol (1997) 1.05
Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzyme-linked immunosorbent assay. J Clin Microbiol (1999) 1.04
Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice. J Immunol (1993) 1.01
Characterization of a 30-kDa Borrelia burgdorferi substrate-binding protein homologue. Res Microbiol (1997) 1.01
Preferential protection of Borrelia burgdorferi sensu stricto by a Salp15 homologue in Ixodes ricinus saliva. J Infect Dis (2008) 1.00
Dissociation of infectivity and pathogenicity in Borrelia burgdorferi. Infect Immun (2001) 0.99
Pathogenicity factors and virulence for rainbow trout (Salmo gairdneri) of motile Aeromonas spp. isolated from a river. J Clin Microbiol (1990) 0.99
Identification of Salp15 homologues in Ixodes ricinus ticks. Vector Borne Zoonotic Dis (2007) 0.99
Ablation of interleukin-12 exacerbates Lyme arthritis in SCID mice. Infect Immun (1997) 0.98
Cloning and characterization of an extracellular temperature-labile serine protease gene from Aeromonas hydrophila. FEMS Microbiol Lett (1991) 0.98
Serologic diagnosis of canine and equine borreliosis: use of recombinant antigens in enzyme-linked immunosorbent assays. J Clin Microbiol (1997) 0.96
Prominent T lymphocyte response to Borrelia burgdorferi from peripheral blood of unexposed donors. Eur J Immunol (1994) 0.96
Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection. J Am Vet Med Assoc (1995) 0.96
Borrelia burgdorferi-induced inflammation facilitates spirochete adaptation and variable major protein-like sequence locus recombination. J Immunol (2001) 0.95
Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis. Infect Immun (1995) 0.95
Blastoschizomyces capitatus infection in acute leukemia patients. Leuk Lymphoma (2000) 0.94
Detection of Ehrlichia chaffeensis DNA in Amblyomma americanum ticks in Connecticut and Rhode Island. J Clin Microbiol (2000) 0.92
B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis. Infect Immun (1997) 0.92
Serologic confirmation of Ehrlichia equi and Borrelia burgdorferi infections in horses from the northeastern United States. J Am Vet Med Assoc (2000) 0.89
Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice. J Immunol (1996) 0.89
The hook protein of Borrelia burgdorferi, encoded by the flgE gene, is serologically recognized in Lyme disease. Clin Diagn Lab Immunol (1995) 0.88
West Nile virus envelope protein: role in diagnosis and immunity. Ann N Y Acad Sci (2001) 0.87
Reactivity of dog sera to whole-cell or recombinant antigens of Borrelia burgdorferi by ELISA and immunoblot analysis. J Med Microbiol (2001) 0.87
Selective anti-inflammatory action of interleukin-11 in murine Lyme disease: arthritis decreases while carditis persists. J Infect Dis (1999) 0.87
Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis. N Engl J Med (2001) 0.86
Efficacy of human Lyme disease vaccine formulations in a mouse model. J Infect Dis (1995) 0.86
Antibodies to Ehrlichia equi in dogs from the northeastern United States. J Am Vet Med Assoc (1997) 0.84
Heat shock protein 70 of the agent of human granulocytic ehrlichiosis binds to Borrelia burgdorferi antibodies. Clin Diagn Lab Immunol (1998) 0.84
Granulocytic ehrlichiosis in tick-immune guinea pigs. Infect Immun (1998) 0.83